Glutamate and ATP signalling in white matter pathology

Journal of Anatomy

Volumn 219, Issue 1, 2011, Pages 53-64

  Matute, Carlos ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

ATP; Demyelination; Excitotoxicity; Glutamate; Human brain; Ischaemia; Oligodendrocyte death

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR 4; GLUTAMATE RECEPTOR 5; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; BRAIN ISCHEMIA; EXCITOTOXICITY; GLIA CELL; GRAY MATTER; HOMEOSTASIS; HUMAN; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL NECROSIS; NERVE FIBER; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERINATAL ISCHEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPINAL CORD INJURY; STROKE; WHITE MATTER;

ADENOSINE TRIPHOSPHATE; BRAIN; BRAIN ISCHEMIA; CELL DEATH; GLUTAMIC ACID; HUMANS; OLIGODENDROGLIA; SIGNAL TRANSDUCTION;

EID: 79958199894     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2010.01339.x     Document Type: Review

References (100)

1. Alberdi E, Sánchez-Gómez MV, Torre I, etal. (2006) Activation of kainate receptors sensitizes oligodendrocytes to complement attack. J Neurosci 26, 3220-3228.
2. Alix JJ, Fern R (2009) Glutamate receptor-mediated ischemic injury of premyelinated central axons. Ann Neurol 66, 682-693.
3. Back SA, Rivkees SA (2004) Emerging concepts in periventricular white matter injury. Semin Perinatol 28, 405-414.
4. Bakiri Y, Burzomato V, Frugier G, etal. (2009) Glutamatergic signaling in the brain's white matter. Neuroscience 158, 266-274.
5. Baltan S (2009) Ischemic injury to white matter: an age-dependent process. Neuroscientist 15, 126-133.
6. Baltan S, Besancon EF, Mbow B, etal. (2008) White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity. J Neurosci 28, 1479-1489.
7. Baptiste DC, Fehlings MG (2006) Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 23, 318-334.
8. Baranzini SE, Srinivasan R, Khankhanian P, etal. (2010) Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain 133, 2603-2611.
9. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55, 458-468.
10. Belachew S, Gallo V (2004) Synaptic and extrasynaptic neurotransmitter receptors in glial precursors' quest for identity. Glia 48, 185-196.
11. Butt AM (2006) Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology. Glia 54, 666-675.
12. Cavaliere F, Amadio S, Sancesario G, etal. (2004) Synaptic P2X7 and oxygen/glucose deprivation in organotypic hippocampal cultures. J Cereb Blood Flow Metab 24, 392-398.
13. Chen L, Brosnan CF (2006) Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes. J Immunol 176, 3115-3126.
14. Comabella M, Craig DW, Morcillo-Suárez C, etal. (2009) Genome-wide scan of 500, 000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis. Arch Neurol 66, 972-978.
15. Constantinou S, Fern R (2009) Conduction block and glial injury induced in developing central white matter by glycine, GABA, noradrenalin, or nicotine, studied in isolated neonatal rat optic nerve. Glia 57, 1168-1177.
16. Cull-Candy SG, Leszkiewicz DN (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 255, re16.
17. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65, 1-105.
18. Davalos D, Grutzendler J, Yang G, etal. (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8, 752-758.
19. Deng W, Wang H, Rosenberg PA, etal. (2004) Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci USA 101, 7751-7756.
20. Desmond DW (2002) Cognition and white matter lesions. Cerebrovasc Dis 13, 1353-1357.
21. Dingledine R, Borges K, Bowie D et al. (1999) The glutamate receptor ion channels. Pharmacol Rev 51, 7-61.
22. Domercq M, Sánchez-Gómez MV, Areso P, etal. (1999) Expression of glutamate transporters in rat optic nerve oligodendrocytes. Eur J Neurosci 11, 2226-2236.
23. Domercq M, Etxebarria E, Pérez-Samartín A, etal. (2005) Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition. Glia 52, 36-46.
24. Domercq M, Sánchez-Gómez MV, Sherwin C, etal. (2007) System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol 178, 6549-6556.
25. Domercq M, Perez-Samartin A, Aparicio D, etal. (2010) P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 58, 730-740.
26. Domingues AM, Taylor M, Fern R (2010) Glia as transmitter sources and sensors in health and disease. Neurochem Int 57, 359-366.
27. Dumont RJ, Okonkwo DO, Verma S, etal. (2001) Acute spinal cord injury, part I: pathophysiological mechanisms. Clin Neuropharmacol 24, 254-264.
28. Färber K, Kettenmann H (2006) Purinergic signaling and microglia. Pflugers Arch 452, 615-621.
29. Fern R, Möller MT (2000) Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 20, 34-42.
30. Fields RD, Burnstock G (2006) Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 7, 423-436.
31. Filley CM (2001) The Behavioral Neurology of White Matter. New York: Oxford University Press.
32. Follett PL, Deng W, Dai W, etal. (2004) Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24, 4412-4420.
33. Fowler JH, McCracken E, Dewar D, etal. (2003) Intracerebral injection of AMPA causes axonal damage in vivo. Brain Res 991, 104-112.
34. Friedle SA, Curet MA, Watters JJ (2010) Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation. Recent Pat CNS Drug Discov 5, 35-45.
35. Goldberg MP, Ransom BR (2003) New light on white matter. Stroke 34, 330-332.
36. González-Fernández E, Sánchez-Gómez MV, Matute C (2010) Activation of adenosine receptors induces apoptosis in oligodendrocytes. Sixth Cajal Winter Conference, Role of Glia in Health and Disease, p. 5.
37. Haynes RL, Billiards SS, Borenstein NS, etal. (2008) Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr Res 63, 656-661.
38. Haynes SE, Hollopeter G, Yang G et al. (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9, 1463-1464.
39. Honda S, Sasaki Y, Ohsawa K, etal. (2001) Extracellular ATP and ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci 21, 1975-1982.
40. Huang YH, Bergles DE (2004) Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol 14, 346-352.
41. 2+ signalling in glial cell pathology in the central nervous system. Eur J Pharmacol 447, 247-260.
42. Kanwar JR, Kanwar RK, Krissansen GW (2004) Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 127, 1313-1331.
43. Káradóttir R, Cavelier P, Bergersen LH, etal. (2005) NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438, 1162-1166.
44. Kettenmann H, Steinhäuser C (2005) Receptors for neurotransmitters and hormones. In Neuroglia, 2nd edn (eds Kettenmann H, Ransom BR), pp. 131-145. New York: Oxford University Press.
45. 2+ release from InsP3-sensitive internal stores in mammalian oligodendrocytes. J Physiol 483, 41-57.
46. Kuckley M, Capetillo-Zarate E, Dietrich D (2007) Vesicular glutamate release from axons in white matter. Nat Neurosci 10, 311-320.
47. Le Feuvre RA, Brough D, Touzani O, etal. (2003) Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J Cereb Blood Flow Metab 23, 381-384.
48. Li S, Stys PK (2000) Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci 20, 1190-1198.
49. Li S, Mealing GA, Morley P, etal. (1999) Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na+-dependent glutamate transport. J Neurosci 19, RC16.
50. Manning SM, Talos DM, Zhou C, etal. (2008) NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 28, 6670-6678.
51. Matute C (1998) Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc Natl Acad Sci USA 95, 10229-10234.
52. Matute C (2006) Oligodendrocyte NMDA receptors: a novel therapeutic target. Trends Mol Med 12, 289-292.
53. Matute C (2010) Calcium dyshomeostasis in white matter pathology. Cell Calcium 47, 150-157.
54. Matute C, Alberdi E, Domercq M, etal. (2001) The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 24, 224-230.
55. Matute C, Domercq M, Sánchez-Gómez MV (2006) Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 53, 212-224.
56. Matute C, Alberdi E, Domercq M, etal. (2007a) Excitotoxic damage to white matter. J Anat 210, 693-702.
57. Matute C, Torre I, Perez-Cerdá F, etal. (2007b) P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci 27, 9525-9533.
58. McCracken E, Fowler JH, Dewar D, etal. (2002) Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502. J Cereb Blood Flow Metab 22, 1090-1097.
59. Micu I, Jiang Q, Coderre E, etal. (2006) NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439, 988-992.
60. Monif M, Reid CA, Powell KL, etal. (2009) The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J Neurosci 29, 3781-3791.
61. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318.
62. Ouardouz M, Malek S, Coderre E, etal. (2006) Complex interplay between glutamate receptors and intracellular Ca2+stores during ischaemia in rat spinal cord white matter. J Physiol 577, 191-204.
63. Ouardouz M, Coderre E, Basak A, etal. (2009a) Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann Neurol 65, 151-159.
64. Ouardouz M, Coderre E, Zamponi GW, etal. (2009b) Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann Neurol 65, 160-166.
65. Pampliega O, Domercq M, Villoslada P, etal. (2008) Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. J Neuroimmunol 195, 194-198.
66. Pantoni L, Garcia JH, Gutierrez JA (1996) Cerebral white matter is highly vulnerable to ischemia. Stroke 27, 1641-1646.
67. Park E, Velumian AA, Fehlings MG (2004) The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21, 754-774.
68. Peng W, Cotrina ML, Han X, etal. (2009) Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc Natl Acad Sci USA 106, 12489-12493.
69. Pérez-Samartín A, Pérez-Cerdá F, Matute C (2009) Methodological tools for research in multiple sclerosis. Eur J Anat 13(Suppl.1), 27.
70. Pitt D, Nagelmeier IE, Wilson HC et al. (2003) Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology 61, 1113-1120.
71. Pitt D, Werner P, Raine CS (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6, 67-70.
72. Prineas JW, McDonald WI, Franklin RJM (2002) Demyelinating diseases. In Greenfield's Neuropathology, Vol. 2 (eds Graham DI, Lantos PL), pp. 471-550. London: Arnold.
73. Rothstein JD, Dykes-Hoberg M, Pardo CA et al. (1996) Knock out of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.
74. Salter MG, Fern R (2005) NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438, 1167-1171.
75. Sánchez-Gómez MV, Alberdi E, Ibarretxe G, etal. (2003) Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J Neurosci 23, 9519-9528.
76. Schäbitz WR, Li F, Fisher M (2000) The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Stroke 31, 1709-1714.
77. Sharp AJ, Polak PE, Simonini V, etal. (2008) P2X7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflammation 8, 33.
78. Skaper SD, Debetto P, Giusti P (2010) The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J 24, 337-345.
79. Smith T, Groom A, Zhu B, etal. (2000) Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6, 62-66.
80. Sperlágh B, Vizi ES, Wirkner K, etal. (2006) P2X7 receptors in the nervous system. Prog Neurobiol 78, 327-346.
81. Srinivasan R, Sailasuta N, Hurd R, etal. (2005) Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128, 1016-1025.
82. Stys PK (2004) White matter injury mechanisms. Curr Mol Med 4, 113-130.
83. Stys PK (2005) General mechanisms of axonal damage and its prevention. J Neurol Sci 233, 3-13.
84. Swanson CJ, Bures M, Johnson MP et al. (2005) Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 4, 131-144.
85. Talos DM, Follett PL, Folkerth RD, etal. (2006) Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. J Comp Neurol 497, 61-77.
86. Tekkök SB, Goldberg MP (2001) AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 21, 4237-4248.
87. Vallejo-Illarramendi A, Domercq M, Pérez-Cerdá F, etal. (2006) Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis 21, 154-164.
88. Verkhratsky A, Kirchhoff F (2007) NMDA receptors in glia. Neuroscientist 13, 28-37.
89. Verkhratsky A, Orkand RK, Kettenmann H (1998) Glial calcium: homeostasis and signaling function. Physiol Rev 78, 99-141.
90. Verkhratsky A, Krishtal OA, Burnstock G (2009) Purinoceptors on neuroglia. Mol Neurobiol 39, 190-208.
91. Volonté C, Amadio S, Cavaliere F, etal. (2003) Extracellular ATP and neurodegeneration. Curr Drug Targets CNS Neurol Disord 2, 403-412.
92. Volpe JJ (2009) Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 8, 110-124.
93. Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6, 626-640.
94. Wang X, Arcuino G, Takano T, etal. (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10, 821-827.
95. Wang LY, Cai WQ, Chen PH, etal. (2009) Downregulation of P2X7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia. Glia 57, 307-319.
96. Werner P, Pitt D, Raine CS (2001) Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50, 169-180.
97. Xu GY, Liu S, Hughes MG, etal. (2008) Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cord. Neuroscience 153, 1034-1047.
98. Zamvil SS, Steinman L (2003) Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis. Neuron 38, 685-688.
99. Zhang K, Sejnowski TJ (2000) A universal scaling law between gray matter and white matter of cerebral cortex. Proc Natl Acad Sci USA 97, 5621-5626.
100. Ziskin JL, Nishiyama A, Rubio M, etal. (2007) Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10, 321-330.